Central 5-HTergic hyperactivity induces myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-like pathophysiology.
Lee, Jin-Seok, Kang, Ji-Yun, Park, Samuel-Young et al. · Journal of translational medicine · 2024 · DOI
Quick Summary
Researchers found that excess serotonin (a brain chemical) in a specific brain region called the dorsal raphe nuclei can cause fatigue and symptoms similar to ME/CFS in mice. They tested this by giving mice high doses of common antidepressants (SSRIs) that increase serotonin levels, and the mice developed severe tiredness, difficulty with physical activity, and problems with their stress response system. This suggests that too much serotonin activity in the brain might be involved in causing ME/CFS symptoms.
Why It Matters
This study provides the first experimental evidence linking excessive serotonin activity in the brain to ME/CFS-like symptoms, offering a potential new biological target for understanding disease mechanisms. If validated in human patients, it could guide development of novel therapies and help explain why some patients may respond differently to standard antidepressant treatments. The animal model developed here provides a tool for testing future treatments.
Observed Findings
High-dose SSRI treatment produced severe fatigue measured by reduced performance on rota-rod tests and rotational wheel activity
HPA axis response to exercise challenge was dysregulated in the serotonin-excess mice
5-HT synthesis inhibition and Htr1a gene knockdown replicated the fatigue and symptom phenotype
Serotonin spillover was confirmed in the dorsal raphe nuclei of treated mice
Inferred Conclusions
Central 5-HTergic hyperactivity is sufficient to induce ME/CFS-like pathophysiology including severe fatigue and neuroendocrine dysfunction
The dorsal raphe nuclei may be a critical site of serotonin dysregulation relevant to ME/CFS mechanisms
Multiple independent methods of increasing serotonin activity produce consistent ME/CFS-like symptoms, strengthening the mechanistic hypothesis
This animal model provides a foundation for testing therapeutic approaches targeting 5-HT system normalization
Remaining Questions
Do ME/CFS patients exhibit elevated serotonin activity or dysfunction in dorsal raphe nuclei compared to healthy controls?
What This Study Does Not Prove
This study does not prove that excessive serotonin is the sole or primary cause of ME/CFS in humans—it demonstrates a mechanism that produces ME/CFS-like symptoms in mice under artificial conditions. The findings do not establish whether ME/CFS patients have abnormally high serotonin levels naturally, nor do they explain all ME/CFS cases or rule out other contributing mechanisms. Animal models do not always translate to human disease.
What initiates serotonin hyperactivity in ME/CFS—is it viral infection, immune activation, genetic factors, or something else?
Which therapeutic approaches can safely reverse serotonin hyperactivity without causing adverse effects in patients?
How do other putative ME/CFS mechanisms (immune dysregulation, mitochondrial dysfunction, post-viral pathology) interact with or relate to 5-HT system abnormalities?